Design and synthesis of novel cytochrome bc1 inhibitors for the treatment of toxoplasmosis
Toxoplasmosis is a highly prolific and neglected disease, and current treatments fail to adequately address the challenges it presents. As such development of new more efficacious treatments, tailored to the complex nature of the infection, is required. The causative parasite Toxoplasma gondii is a...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leeds
2018
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766436 |